Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12‐month GENERAL study

Abstract

In routine clinical care of patients with IGE, perampanel improved seizure outcomes for GTCS, myoclonic seizures, and absence seizures, with few discontinuations due to adverse events. This is the first real-world evidence with perampanel across different seizure types in IGE.